BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38313836)

  • 1. Association between triglyceride glucose index and adverse clinical outcomes in patients with acute myocardial infarction and LDL-C≤1.8 mmol/L who underwent percutaneous coronary intervention: a prospective cohort study.
    Zhao HW; Wang Y; Wang CF; Meng QK
    Front Endocrinol (Lausanne); 2023; 14():1323615. PubMed ID: 38313836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
    Luo E; Wang D; Yan G; Qiao Y; Liu B; Hou J; Tang C
    Cardiovasc Diabetol; 2019 Nov; 18(1):150. PubMed ID: 31722708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention.
    Yang J; Tang YD; Zheng Y; Li C; Zhou Q; Gao J; Meng X; Zhang K; Wang W; Shao C
    Front Endocrinol (Lausanne); 2021; 12():710240. PubMed ID: 34489866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study.
    Cheng Y; Fang Z; Zhang X; Wen Y; Lu J; He S; Xu B
    Cardiovasc Diabetol; 2023 Mar; 22(1):75. PubMed ID: 36997935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Triglyceride-Glucose Index is Associated with Poor Cardiovascular Outcomes in Nondiabetic Patients with ACS with LDL-C below 1.8 mmol/L.
    Zhang Y; Ding X; Hua B; Liu Q; Gao H; Chen H; Zhao XQ; Li W; Li H
    J Atheroscler Thromb; 2022 Feb; 29(2):268-281. PubMed ID: 33536384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents.
    Zhang Y; Chu C; Zhong Z; Luo YB; Ning FF; Guo N
    Front Endocrinol (Lausanne); 2023; 14():1101952. PubMed ID: 36875470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study.
    Song Y; Cui K; Yang M; Song C; Yin D; Dong Q; Gao Y; Dou K
    Cardiovasc Diabetol; 2023 Jul; 22(1):180. PubMed ID: 37454147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study.
    Zhang Z; Zhao L; Lu Y; Meng X; Zhou X
    Cardiovasc Diabetol; 2023 Jun; 22(1):161. PubMed ID: 37386494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of the triglyceride-glucose index for cardiovascular events in patients with coronary chronic total occlusion.
    Li Y; He S; Wu Z; Li W; Jian W; Cheng Z; Wang C; Shi Y; Liu J
    Cardiovasc Diabetol; 2022 Aug; 21(1):149. PubMed ID: 35941586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive effect of triglyceride‑glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China.
    Zhang Y; Ding X; Hua B; Liu Q; Gao H; Chen H; Zhao XQ; Li W; Li H
    Cardiovasc Diabetol; 2021 Feb; 20(1):43. PubMed ID: 33573649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triglyceride-glucose index level and variability and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational cohort study.
    Wang Y; Wang Y; Sun S; Liu X; Zhao W; Li W; Suo M; Wu Z; Wu X
    Lipids Health Dis; 2022 Dec; 21(1):134. PubMed ID: 36482415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.
    Zhao X; Wang Y; Chen R; Li J; Zhou J; Liu C; Zhou P; Sheng Z; Chen Y; Song L; Zhao H; Yan H
    Cardiovasc Diabetol; 2021 Jun; 20(1):131. PubMed ID: 34183007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
    Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
    Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
    Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
    Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
    Tao S; Yu L; Li J; Xie Z; Huang L; Yang D; Tan Y; Zhang W; Huang X; Xue T
    Cardiovasc Diabetol; 2023 Nov; 22(1):322. PubMed ID: 38017540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
    Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
    Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value of the Triglyceride-Glucose Index in Forecasting Ten-Year Major Adverse Cardiovascular Events in Non-Diabetic Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Köktürk U; Onalan O; Somuncu MU; Uygur B; Erbay İ; Çakan F; Avcı A
    Turk Kardiyol Dern Ars; 2024 Jun; 52(4):253-259. PubMed ID: 38829642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.